NYSE:ACHHealthcare
Accendra Health (ACH) Q1 Loss Narrows Challenging Bearish Profitability Narratives
Accendra Health (ACH) has kicked off Q1 2026 with revenue of US$627.8 million and a reported loss of US$6.5 million, translating to EPS of US$0.08, while trailing twelve month revenue sits at about US$2.7 billion with a loss of US$105.3 million and EPS of US$1.37. Over recent quarters the company has seen revenue move between US$673.9 million in Q1 2025 and US$709.0 million in Q4 2025, alongside EPS shifting from a loss of US$0.05 in Q1 2025 to a loss of US$0.12 in Q4 2025, before the latest...